Nicolas André1, Shripad Banavali2, Eddy Pasquier3. 1. Inserm UMR_S 911, Centre de Recherche en Oncologie biologique et Oncopharmacologie, 27 Boulevard Jean Moulin, Faculté de Pharmacie, Aix-Marseille Université; Service d'Hématologie &Oncologie Pédiatrique, AP-HM; and the Metronomics Global Health Initiative, 13005 Marseille, France. 2. Department of Medical Oncology, Tata Memorial Centre, Dr. E Borges Road, 400012, Parel, Mumbai, India; and the Metronomics Global Health Initiative, 13005 Marseille, France. 3. Inserm UMR_S 911, Centre de Recherche en Oncologie biologique et Oncopharmacologie, 27 Boulevard Jean Moulin, Faculté de Pharmacie, Aix-Marseille Université; and the Metronomics Global Health Initiative, 13005 Marseille, France.
Authors: Ian Magrath; Eva Steliarova-Foucher; Sidnei Epelman; Raul C Ribeiro; Mhamed Harif; Chi-Kong Li; Rejin Kebudi; Scott D Macfarlane; Scott C Howard Journal: Lancet Oncol Date: 2013-02-20 Impact factor: 41.316
Authors: Lisa S Kahalley; M Douglas Ris; David R Grosshans; M Fatih Okcu; Arnold C Paulino; Murali Chintagumpala; Bartlett D Moore; Danielle Guffey; Charles G Minard; Heather H Stancel; Anita Mahajan Journal: J Clin Oncol Date: 2016-01-25 Impact factor: 44.544
Authors: Adriana Rosé; Nicolas André; Viviana R Rozados; Leandro E Mainetti; Mauricio Menacho Márquez; María José Rico; Paula Schaiquevich; Milena Villarroel; Lauro Gregianin; Jaume Mora Graupera; Wendy Gómez García; Sidnei Epelman; Carlos Alasino; Daniel Alonso; Guillermo Chantada; O Graciela Scharovsky Journal: Ecancermedicalscience Date: 2016-09-06